La Jolla, CA, United States of America

Abraham I Braude

This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 1995.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Abraham I Braude

Introduction

Abraham I Braude is a notable inventor based in La Jolla, California. He is recognized for his significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. His work has implications for medical research and therapeutic applications.

Latest Patents

Abraham I Braude holds a patent for a human monoclonal antibody to lipid A of Gram-negative bacteria. This patent, which is identified as a human monoclonal antibody, C5, is specific for lipid A of the endotoxin core of Gram-negative bacteria. The hybridoma cell line that produces this antibody is created through the fusion of lipid A sensitized lymphocytes and an appropriate fusion partner. He has 1 patent to his name.

Career Highlights

Braude's career is marked by his association with Leland Stanford Junior University, where he has contributed to various research initiatives. His work has advanced the understanding of immune responses to bacterial infections, showcasing his expertise in the field.

Collaborations

Throughout his career, Braude has collaborated with esteemed colleagues, including Henry S Kaplan and Nelson N Teng. These collaborations have further enriched his research and expanded the impact of his innovations.

Conclusion

Abraham I Braude's contributions to the field of immunology through his patent on monoclonal antibodies highlight his role as an influential inventor. His work continues to inspire advancements in medical research and therapeutic development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…